Liquid Biopsy Market (2026 - 2033) Size, Share & Trends Analysis Report By Biomarker (Exosomes, Circulating Nucleic Acids, CTC), By Technology, By Sample Type, By Application, By Clinical Application, By End Use, By Product, By Region, And Segment Forecasts

Table of Contents

Chapter 1. Methodology and Scope
                    1.1. Market Segmentation
                        1.1.1. Market Definitions
                    1.2. Objectives
                        1.2.1. OBJECTIVE - 1
                        1.2.2. OBJECTIVE - 2
                        1.2.3. OBJECTIVE - 3
                    1.3. Research Methodology
                    1.4. Information Procurement
                        1.4.1. PURCHASED DATABASE
                        1.4.2. GVR’S INTERNAL DATABASE
                        1.4.3. SECONDARY SOURCES
                        1.4.4. PRIMARY RESEARCH
                    1.5. Information or Data Analysis
                        1.5.1. DATA ANALYSIS MODELS
                    1.6. Market Formulation & Validation
                    1.7. Model Details
                        1.7.1. COMMODITY FLOW ANALYSIS
                    1.8. List of Secondary Sources
                    1.9. List of Abbreviations
                    1.10. List of Primary Sources
Chapter 2. Executive Summary
                    2.1. Market Snapshot
                    2.2. Segment Snapshot
                    2.3. Competitive Landscape Snapshot
Chapter 3. Market Variables, Trends, & Scope
                    3.1. Market Segmentation and Scope
                    3.2. Market Lineage Outlook
                        3.2.1. Parent Market Outlook
                        3.2.2. Related/Ancillary Market Outlook
                    3.3. Market Dynamics
                    3.4. Market Drivers
                        3.4.1. Increasing prevalence of cancer
                        3.4.2. Growing geriatric population
                        3.4.3. Technological advancements
                        3.4.4. Increasing preference for noninvasive treatment
                    3.5. Market Restraint Analysis
                        3.5.1. Patent expiry of blockbuster drugs prescribed
                    3.6. Business Environment Analysis
                        3.6.1. SWOT Analysis; By Factor (Political & Legal, Economic And Technological)
                        3.6.2. Porter’s Five Forces Analysis
Chapter 4. Sample Type Business Analysis
                    4.1. Liquid Biopsy Market: Type Movement Analysis
                    4.2. Blood Sample
                        4.2.1. Blood Sample Market, 2021 - 2033 (USD Million)
                    4.3. Others
                        4.3.1. Others Market, 2021 - 2033 (USD Million)
Chapter 5. Biomarker Business Analysis
                    5.1. Liquid Biopsy Market: Biomarker Movement Analysis
                    5.2. Circulating Tumor Cells (CTCs)
                        5.2.1. Circulating Tumor Cells (CTCs) Market, 2021 - 2033 (USD Million)
                    5.3. Circulating Nucleic Acids
                        5.3.1. Circulating Nucleic Acids Market, 2021 - 2033 (USD Million)
                    5.4. Exosomes/Microvesicles
                        5.4.1. Exosomes/Microvesicles Market, 2021 - 2033 (USD Million)
                    5.5. Others
                        5.5.1. Others Market, 2021 - 2033 (USD Million)
Chapter 6. Technology Business Analysis
                    6.1. Liquid Biopsy Market: Technology Movement Analysis
                    6.2. Multi-gene-parallel Analysis (NGS)
                        6.2.1. Multi-gene-parallel Analysis (NGS) Market, 2021 - 2033 (USD Million)
                    6.3. Single Gene Analysis (PCR Microarrays)
                        6.3.1. Single Gene Analysis (PCR Microarrays) Market, 2021 - 2033 (USD Million)
Chapter 7. Application Business Analysis
                    7.1. Liquid Biopsy Market: Application Movement Analysis
                    7.2. Cancer
                        7.2.1. Cancer Market, 2021 - 2033 (USD Million)
                            7.2.1.1. Lung Cancer
                                7.2.1.1.1. Lung Cancer Market, 2021 - 2033 (USD Million)
                            7.2.1.2. Prostate Cancer
                                7.2.1.2.1. Prostate Cancer Market, 2021 - 2033 (USD Million)
                            7.2.1.3. Breast Cancer
                                7.2.1.3.1. Breast Cancer Market, 2021 - 2033 (USD Million)
                            7.2.1.4. Colorectal Cancer
                                7.2.1.4.1. Colorectal Cancer Market, 2021 - 2033 (USD Million)
                            7.2.1.5. Leukemia
                                7.2.1.5.1. Leukemia Market, 2021 - 2033 (USD Million)
                            7.2.1.6. Gastrointestinal Cancer
                                7.2.1.6.1. Gastrointestinal Cancer Market, 2021 - 2033 (USD Million)
                            7.2.1.7. Others
                                7.2.1.7.1. Others Market, 2021 - 2033 (USD Million)
                    7.3. Reproductive Health
                        7.3.1. Reproductive Health Market, 2021 - 2033 (USD Million)
                    7.4. Others
                        7.4.1. Others Market, 2021 - 2033 (USD Million)
Chapter 8. End Use Business Analysis
                    8.1. Liquid Biopsy Market: End-Use Movement Analysis
                    8.2. Hospitals and Laboratories
                        8.2.1. Hospitals and Laboratories Market, 2021 - 2033 (USD Million)
                    8.3. Specialty Clinics
                        8.3.1. Specialty Clinics Market, 2021 - 2033 (USD Million)
                    8.4. Academic and Research Centers
                        8.4.1. Academic and Research Centers Market, 2021 - 2033 (USD Million)
                    8.5. Others
                        8.5.1. Others Liquid Biopsy Market, 2021 - 2033 (USD Million)
Chapter 9. Clinical Application Business Analysis
                    9.1. Liquid Biopsy Market: Clinical Application Movement Analysis
                    9.2. Therapy Selection
                        9.2.1. Therapy Selection Market, 2021 - 2033 (USD Million)
                    9.3. Treatment Monitoring
                        9.3.1. Treatment Monitoring Market, 2021 - 2033 (USD Million)
                    9.4. Early Cancer Screening
                        9.4.1. Early Cancer Screening Market, 2021 - 2033 (USD Million)
                    9.5. Recurrence Monitoring
                        9.5.1. Recurrence Monitoring Market, 2021 - 2033 (USD Million)
                    9.6. Others
                        9.6.1. Others Liquid Biopsy Market, 2021 - 2033 (USD Million)
Chapter 10. Product Business Analysis
                    10.1. Liquid Biopsy Market: Product Movement Analysis
                    10.2. Instruments
                        10.2.1. Instruments Market, 2021 - 2033 (USD Million)
                    10.3. Consumables Kits and Reagents
                        10.3.1. Consumables Kits and Reagents Market, 2021 - 2033 (USD Million)
                    10.4. Software and Services
                        10.4.1. Software and Services Market, 2021 - 2033 (USD Million)
Chapter 11. Regional Business Analysis
                    11.1. Liquid Biopsy Market Share By Region, 2025 & 2033
                    11.2. North America
                        11.2.1. North America Liquid biopsy market, 2021 - 2033 (USD Million)
                        11.2.2. U.S.
                            11.2.2.1. Key Country Dynamics
                            11.2.2.2. Target Disease Prevalence
                            11.2.2.3. Competitive Scenario
                            11.2.2.4. Regulatory Framework
                            11.2.2.5. Reimbursement Scenario
                            11.2.2.6. U.S. Liquid biopsy market, 2021 - 2033 (USD MILLION)
                        11.2.3. Canada
                            11.2.3.1. Key Country Dynamics
                            11.2.3.2. Target Disease Prevalence
                            11.2.3.3. Competitive Scenario
                            11.2.3.4. Regulatory Framework
                            11.2.3.5. Reimbursement Scenario
                            11.2.3.6. Canada Liquid biopsy market, 2021 - 2033 (USD Million)
                        11.2.4. Mexico
                            11.2.4.1. Key Country Dynamics
                            11.2.4.2. Target Disease Prevalence
                            11.2.4.3. Competitive Scenario
                            11.2.4.4. Regulatory Framework
                            11.2.4.5. Reimbursement Scenario
                            11.2.4.6. Mexico Liquid biopsy market, 2021 - 2033 (USD Million)
                    11.3. Europe
                        11.3.1. Europe Liquid biopsy market, 2021 - 2033 (USD Million)
                        11.3.2. Germany
                            11.3.2.1. Key Country Dynamics
                            11.3.2.2. Target Disease Prevalence
                            11.3.2.3. Competitive Scenario
                            11.3.2.4. Regulatory Framework
                            11.3.2.5. Reimbursement Scenario
                            11.3.2.6. Germany Liquid biopsy market, 2021 - 2033 (USD Million)
                        11.3.3. UK
                            11.3.3.1. Key Country Dynamics
                            11.3.3.2. Target Disease Prevalence
                            11.3.3.3. Competitive Scenario
                            11.3.3.4. Regulatory Framework
                            11.3.3.5. Reimbursement Scenario
                            11.3.3.6. UK Liquid biopsy market, 2021 - 2033 (USD Million)
                        11.3.4. France
                            11.3.4.1. Key Country Dynamics
                            11.3.4.2. Target Disease Prevalence
                            11.3.4.3. Competitive Scenario
                            11.3.4.4. Regulatory Framework
                            11.3.4.5. Reimbursement Scenario
                            11.3.4.6. France Liquid biopsy market, 2021 - 2033 (USD Million)
                        11.3.5. Italy
                            11.3.5.1. Key Country Dynamics
                            11.3.5.2. Target Disease Prevalence
                            11.3.5.3. Competitive Scenario
                            11.3.5.4. Regulatory Framework
                            11.3.5.5. Reimbursement Scenario
                            11.3.5.6. Italy Liquid biopsy market, 2021 - 2033 (USD Million)
                        11.3.6. Spain
                            11.3.6.1. Key Country Dynamics
                            11.3.6.2. Target Disease Prevalence
                            11.3.6.3. Competitive Scenario
                            11.3.6.4. Regulatory Framework
                            11.3.6.5. Reimbursement Scenario
                            11.3.6.6. Spain Liquid biopsy market, 2021 - 2033 (USD Million)
                        11.3.7. Denmark
                            11.3.7.1. Key Country Dynamics
                            11.3.7.2. Target Disease Prevalence
                            11.3.7.3. Competitive Scenario
                            11.3.7.4. Regulatory Framework
                            11.3.7.5. Reimbursement Scenario
                            11.3.7.6. Denmark Liquid biopsy market, 2021 - 2033 (USD Million)
                        11.3.8. Sweden
                            11.3.8.1. Key Country Dynamics
                            11.3.8.2. Target Disease Prevalence
                            11.3.8.3. Competitive Scenario
                            11.3.8.4. Regulatory Framework
                            11.3.8.5. Reimbursement Scenario
                            11.3.8.6. Sweden Liquid biopsy market, 2021 - 2033 (USD Million)
                        11.3.9. Norway
                            11.3.9.1. Key Country Dynamics
                            11.3.9.2. Target Disease Prevalence
                            11.3.9.3. Competitive Scenario
                            11.3.9.4. Regulatory Framework
                            11.3.9.5. Reimbursement Scenario
                            11.3.9.6. Norway Liquid biopsy market, 2021 - 2033 (USD Million)
                    11.4. Asia Pacific
                        11.4.1. Asia Pacific Liquid biopsy market, 2021 - 2033 (USD Million)
                        11.4.2. Japan
                            11.4.2.1. Key Country Dynamics
                            11.4.2.2. Target Disease Prevalence
                            11.4.2.3. Competitive Scenario
                            11.4.2.4. Regulatory Framework
                            11.4.2.5. Reimbursement Scenario
                            11.4.2.6. Japan Liquid biopsy market, 2021 - 2033 (USD Million)
                        11.4.3. China
                            11.4.3.1. Key Country Dynamics
                            11.4.3.2. Target Disease Prevalence
                            11.4.3.3. Competitive Scenario
                            11.4.3.4. Regulatory Framework
                            11.4.3.5. Reimbursement Scenario
                            11.4.3.6. China Liquid biopsy market, 2021 - 2033 (USD Million)
                        11.4.4. India
                            11.4.4.1. Key Country Dynamics
                            11.4.4.2. Target Disease Prevalence
                            11.4.4.3. Competitive Scenario
                            11.4.4.4. Regulatory Framework
                            11.4.4.5. Reimbursement Scenario
                            11.4.4.6. India Liquid biopsy market, 2021 - 2033 (USD Million)
                        11.4.5. South Korea
                            11.4.5.1. Key Country Dynamics
                            11.4.5.2. Target Disease Prevalence
                            11.4.5.3. Competitive Scenario
                            11.4.5.4. Regulatory Framework
                            11.4.5.5. Reimbursement Scenario
                            11.4.5.6. South Korea Liquid biopsy market, 2021 - 2033 (USD Million)
                        11.4.6. Australia
                            11.4.6.1. Key Country Dynamics
                            11.4.6.2. Target Disease Prevalence
                            11.4.6.3. Competitive Scenario
                            11.4.6.4. Regulatory Framework
                            11.4.6.5. Reimbursement Scenario
                            11.4.6.6. Australia Liquid biopsy market, 2021 - 2033 (USD Million)
                        11.4.7. Thailand
                            11.4.7.1. Key Country Dynamics
                            11.4.7.2. Target Disease Prevalence
                            11.4.7.3. Competitive Scenario
                            11.4.7.4. Regulatory Framework
                            11.4.7.5. Reimbursement Scenario
                            11.4.7.6. Thailand Liquid biopsy market, 2021 - 2033 (USD Million)
                    11.5. Latin America
                        11.5.1. Latin America Liquid biopsy market, 2021 - 2033 (USD Million)
                        11.5.2. Brazil
                            11.5.2.1. Key Country Dynamics
                            11.5.2.2. Target Disease Prevalence
                            11.5.2.3. Competitive Scenario
                            11.5.2.4. Regulatory Framework
                            11.5.2.5. Reimbursement Scenario
                            11.5.2.6. Brazil Liquid biopsy market, 2021 - 2033 (USD Million)
                        11.5.3. Argentina
                            11.5.3.1. Key Country Dynamics
                            11.5.3.2. Target Disease Prevalence
                            11.5.3.3. Competitive Scenario
                            11.5.3.4. Regulatory Framework
                            11.5.3.5. Reimbursement Scenario
                            11.5.3.6. Argentina Liquid biopsy market, 2021 - 2033 (USD Million)
                    11.6. Middle East and Africa
                        11.6.1. Middle East and Africa Liquid biopsy market, 2021 - 2033 (USD Million)
                        11.6.2. South Africa
                            11.6.2.1. Key Country Dynamics
                            11.6.2.2. Target Disease Prevalence
                            11.6.2.3. Competitive Scenario
                            11.6.2.4. Regulatory Framework
                            11.6.2.5. Reimbursement Scenario
                            11.6.2.6. South Africa Liquid biopsy market, 2021 - 2033 (USD Million)
                        11.6.3. Saudi Arabia
                            11.6.3.1. Key Country Dynamics
                            11.6.3.2. Target Disease Prevalence
                            11.6.3.3. Competitive Scenario
                            11.6.3.4. Regulatory Framework
                            11.6.3.5. Reimbursement Scenario
                            11.6.3.6. Saudi Arabia Liquid biopsy market, 2021 - 2033 (USD Million)
                        11.6.4. UAE
                            11.6.4.1. Key Country Dynamics
                            11.6.4.2. Target Disease Prevalence
                            11.6.4.3. Competitive Scenario
                            11.6.4.4. Regulatory Framework
                            11.6.4.5. Reimbursement Scenario
                            11.6.4.6. UAE Liquid biopsy market, 2021 - 2033 (USD Million)
                        11.6.5. Kuwait
                            11.6.5.1. Key Country Dynamics
                            11.6.5.2. Target Disease Prevalence
                            11.6.5.3. Competitive Scenario
                            11.6.5.4. Regulatory Framework
                            11.6.5.5. Reimbursement Scenario
                            11.6.5.6. Kuwait Liquid biopsy market, 2021 - 2033 (USD Million)
Chapter 12. Competitive Landscape
                    12.1. Participant’s overview
                    12.2. Financial performance
                    12.3. Participant categorization
                        12.3.1. Market Leaders
                        12.3.2. Liquid Biopsy Market Share Analysis, 2025
                        12.3.3. Company Profiles
                            12.3.3.1. ANGLE plc
                                12.3.3.1.1. Company Overview
                                12.3.3.1.2. Financial Performance
                                12.3.3.1.3. Product Benchmarking
                                12.3.3.1.4. Strategic Initiatives
                            12.3.3.2. Oncimmune Holdings PLC
                                12.3.3.2.1. Company Overview
                                12.3.3.2.2. Financial Performance
                                12.3.3.2.3. Product Benchmarking
                                12.3.3.2.4. Strategic Initiatives
                            12.3.3.3. Guardant Health
                                12.3.3.3.1. Company Overview
                                12.3.3.3.2. Financial Performance
                                12.3.3.3.3. Product Benchmarking
                                12.3.3.3.4. Strategic Initiatives
                            12.3.3.4. Myriad Genetics, Inc.
                                12.3.3.4.1. Company Overview
                                12.3.3.4.2. Financial Performance
                                12.3.3.4.3. Product Benchmarking
                                12.3.3.4.4. Strategic Initiatives
                            12.3.3.5. Biocept, Inc.
                                12.3.3.5.1. Company Overview
                                12.3.3.5.2. Financial Performance
                                12.3.3.5.3. Product Benchmarking
                                12.3.3.5.4. Strategic Initiatives
                            12.3.3.6. Lucence Health Inc.
                                12.3.3.6.1. Company Overview
                                12.3.3.6.2. Financial Performance
                                12.3.3.6.3. Product Benchmarking
                                12.3.3.6.4. Strategic Initiatives
                            12.3.3.7. Freenome Holdings, Inc.
                                12.3.3.7.1. Company Overview
                                12.3.3.7.2. Financial Performance
                                12.3.3.7.3. Product Benchmarking
                                12.3.3.7.4. Strategic Initiatives
                            12.3.3.8. F. Hoffmann-La Roche Ltd.
                                12.3.3.8.1. Company Overview
                                12.3.3.8.2. Financial Performance
                                12.3.3.8.3. Product Benchmarking
                                12.3.3.8.4. Strategic Initiatives
                            12.3.3.9. QIAGEN
                                12.3.3.9.1. Company Overview
                                12.3.3.9.2. Financial Performance
                                12.3.3.9.3. Product Benchmarking
                                12.3.3.9.4. Strategic Initiatives
                            12.3.3.10. Illumina, Inc.
                                12.3.3.10.1. Company Overview
                                12.3.3.10.2. Financial Performance
                                12.3.3.10.3. Product Benchmarking
                                12.3.3.10.4. Strategic Initiatives
                            12.3.3.11. Thermo Fisher Scientific, Inc.
                                12.3.3.11.1. Company Overview
                                12.3.3.11.2. Financial Performance
                                12.3.3.11.3. Product Benchmarking
                                12.3.3.11.4. Strategic Initiatives
                            12.3.3.12. Epigenomics AG
                                12.3.3.12.1. Company Overview
                                12.3.3.12.2. Financial Performance
                                12.3.3.12.3. Product Benchmarking
                                12.3.3.12.4. Strategic Initiatives
                        12.3.4. Strategy Mapping
                            12.3.4.1. Expansion
                            12.3.4.2. Acquisition
                            12.3.4.3. Collaborations
                            12.3.4.4. Disease Type/Drug Class Launch
                            12.3.4.5. Partnerships
                            12.3.4.6. Others

List of Tables

Table 1 List of Tables
Table 2 Global Liquid Biopsy Market, By Region, 2021 - 2033 (USD Million)
Table 3 Global Liquid Biopsy Market, By Sample Type, 2021 - 2033 (USD Million)
Table 4 Global Liquid Biopsy Market, By Biomarker, 2021 - 2033 (USD Million)
Table 5 Global Liquid Biopsy Market, By Technology, 2021 - 2033 (USD Million)
Table 6 Global Liquid Biopsy Market, By Application, 2021 - 2033 (USD Million)
Table 7 Global Liquid Biopsy Market, By End Use, 2021 - 2033 (USD Million)
Table 8 Global Liquid Biopsy Market, By Clinical Application, 2021 - 2033 (USD Million)
Table 9 Global Liquid Biopsy Market, By Product, 2021 - 2033 (USD Million)
Table 10 North America Liquid Biopsy Market, By Country, 2021 - 2033 (USD Million)
Table 11 North America Liquid Biopsy Market, By Sample Type, 2021 - 2033 (USD Million)
Table 12 North America Liquid Biopsy Market, By Biomarker, 2021 - 2033 (USD Million)
Table 13 North America Liquid Biopsy Market, By Technology, 2021 - 2033 (USD Million)
Table 14 North America Liquid Biopsy Market, By Application, 2021 - 2033 (USD Million)
Table 15 North America Liquid Biopsy Market, By End Use, 2021 - 2033 (USD Million)
Table 16 North America Liquid Biopsy Market, By Clinical Application, 2021 - 2033 (USD Million)
Table 17 North America Liquid Biopsy Market, By Product, 2021 - 2033 (USD Million)
Table 18 U.S. Liquid Biopsy Market, By Sample Type, 2021 - 2033 (USD Million)
Table 19 U.S. Liquid Biopsy Market, By Biomarker, 2021 - 2033 (USD Million)
Table 20 U.S. Liquid Biopsy Market, By Technology, 2021 - 2033 (USD Million)
Table 21 U.S. Liquid Biopsy Market, By Application, 2021 - 2033 (USD Million)
Table 22 U.S. Liquid Biopsy Market, By End Use, 2021 - 2033 (USD Million)
Table 23 U.S. Liquid Biopsy Market, By Clinical Application, 2021 - 2033 (USD Million)
Table 24 U.S. Liquid Biopsy Market, By Product, 2021 - 2033 (USD Million)
Table 25 Canada Liquid Biopsy Market, By Sample Type, 2021 - 2033 (USD Million)
Table 26 Canada Liquid Biopsy Market, By Biomarker, 2021 - 2033 (USD Million)
Table 27 Canada Liquid Biopsy Market, By Technology, 2021 - 2033 (USD Million)
Table 28 Canada Liquid Biopsy Market, By Application, 2021 - 2033 (USD Million)
Table 29 Canada Liquid Biopsy Market, By End Use, 2021 - 2033 (USD Million)
Table 30 Canada Liquid Biopsy Market, By Clinical Application, 2021 - 2033 (USD Million)
Table 31 Canada Liquid Biopsy Market, By Product, 2021 - 2033 (USD Million)
Table 32 Mexico Liquid Biopsy Market, By Sample Type, 2021 - 2033 (USD Million)
Table 33 Mexico Liquid Biopsy Market, By Biomarker, 2021 - 2033 (USD Million)
Table 34 Mexico Liquid Biopsy Market, By Technology, 2021 - 2033 (USD Million)
Table 35 Mexico Liquid Biopsy Market, By Application, 2021 - 2033 (USD Million)
Table 36 Mexico Liquid Biopsy Market, By End Use, 2021 - 2033 (USD Million)
Table 37 Mexico Liquid Biopsy Market, By Clinical Application, 2021 - 2033 (USD Million)
Table 38 Mexico Liquid Biopsy Market, By Product, 2021 - 2033 (USD Million)
Table 39 Europe Liquid Biopsy Market, By Country, 2021 - 2033 (USD Million)
Table 40 Europe Liquid Biopsy Market, By Sample Type, 2021 - 2033 (USD Million)
Table 41 Europe Liquid Biopsy Market, By Biomarker, 2021 - 2033 (USD Million)
Table 42 Europe Liquid Biopsy Market, By Technology, 2021 - 2033 (USD Million)
Table 43 Europe Liquid Biopsy Market, By Application, 2021 - 2033 (USD Million)
Table 44 Europe Liquid Biopsy Market, By End Use, 2021 - 2033 (USD Million)
Table 45 Europe Liquid Biopsy Market, By Clinical Application, 2021 - 2033 (USD Million)
Table 46 Europe Liquid Biopsy Market, By Product, 2021 - 2033 (USD Million)
Table 47 UK Liquid Biopsy Market, By Sample Type, 2021 - 2033 (USD Million)
Table 48 UK Liquid Biopsy Market, By Biomarker, 2021 - 2033 (USD Million)
Table 49 UK Liquid Biopsy Market, By Technology, 2021 - 2033 (USD Million)
Table 50 UK Liquid Biopsy Market, By Application, 2021 - 2033 (USD Million)
Table 51 UK Liquid Biopsy Market, By End Use, 2021 - 2033 (USD Million)
Table 52 UK Liquid Biopsy Market, By Clinical Application, 2021 - 2033 (USD Million)
Table 53 UK Liquid Biopsy Market, By Product, 2021 - 2033 (USD Million)
Table 54 Germany Liquid Biopsy Market, By Sample Type, 2021 - 2033 (USD Million)
Table 55 Germany Liquid Biopsy Market, By Biomarker, 2021 - 2033 (USD Million)
Table 56 Germany Liquid Biopsy Market, By Technology, 2021 - 2033 (USD Million)
Table 57 Germany Liquid Biopsy Market, By Application, 2021 - 2033 (USD Million)
Table 58 Germany Liquid Biopsy Market, By End Use, 2021 - 2033 (USD Million)
Table 59 Germany Liquid Biopsy Market, By Clinical Application, 2021 - 2033 (USD Million)
Table 60 Germany Liquid Biopsy Market, By Product, 2021 - 2033 (USD Million)
Table 61 France Liquid Biopsy Market, By Sample Type, 2021 - 2033 (USD Million)
Table 62 France Liquid Biopsy Market, By Biomarker, 2021 - 2033 (USD Million)
Table 63 France Liquid Biopsy Market, By Technology, 2021 - 2033 (USD Million)
Table 64 France Liquid Biopsy Market, By Application, 2021 - 2033 (USD Million)
Table 65 France Liquid Biopsy Market, By End Use, 2021 - 2033 (USD Million)
Table 66 France Liquid Biopsy Market, By Clinical Application, 2021 - 2033 (USD Million)
Table 67 France Liquid Biopsy Market, By Product, 2021 - 2033 (USD Million)
Table 68 Italy Liquid Biopsy Market, By Sample Type, 2021 - 2033 (USD Million)
Table 69 Italy Liquid Biopsy Market, By Biomarker, 2021 - 2033 (USD Million)
Table 70 Italy Liquid Biopsy Market, By Technology, 2021 - 2033 (USD Million)
Table 71 Italy Liquid Biopsy Market, By Application, 2021 - 2033 (USD Million)
Table 72 Italy Liquid Biopsy Market, By End Use, 2021 - 2033 (USD Million)
Table 73 Italy Liquid Biopsy Market, By Clinical Application, 2021 - 2033 (USD Million)
Table 74 Italy Liquid Biopsy Market, By Product, 2021 - 2033 (USD Million)
Table 75 Spain Liquid Biopsy Market, By Sample Type, 2021 - 2033 (USD Million)
Table 76 Spain Liquid Biopsy Market, By Biomarker, 2021 - 2033 (USD Million)
Table 77 Spain Liquid Biopsy Market, By Technology, 2021 - 2033 (USD Million)
Table 78 Spain Liquid Biopsy Market, By Application, 2021 - 2033 (USD Million)
Table 79 Spain Liquid Biopsy Market, By End Use, 2021 - 2033 (USD Million)
Table 80 Spain Liquid Biopsy Market, By Clinical Application, 2021 - 2033 (USD Million)
Table 81 Spain Liquid Biopsy Market, By Product, 2021 - 2033 (USD Million)
Table 82 Denmark Liquid Biopsy Market, By Sample Type, 2021 - 2033 (USD Million)
Table 83 Denmark Liquid Biopsy Market, By Biomarker, 2021 - 2033 (USD Million)
Table 84 Denmark Liquid Biopsy Market, By Technology, 2021 - 2033 (USD Million)
Table 85 Denmark Liquid Biopsy Market, By Application, 2021 - 2033 (USD Million)
Table 86 Denmark Liquid Biopsy Market, By End Use, 2021 - 2033 (USD Million)
Table 87 Denmark Liquid Biopsy Market, By Clinical Application, 2021 - 2033 (USD Million)
Table 88 Denmark Liquid Biopsy Market, By Product, 2021 - 2033 (USD Million)
Table 89 Sweden Liquid Biopsy Market, By Sample Type, 2021 - 2033 (USD Million)
Table 90 Sweden Liquid Biopsy Market, By Biomarker, 2021 - 2033 (USD Million)
Table 91 Sweden Liquid Biopsy Market, By Technology, 2021 - 2033 (USD Million)
Table 92 Sweden Liquid Biopsy Market, By Application, 2021 - 2033 (USD Million)
Table 93 Sweden Liquid Biopsy Market, By End Use, 2021 - 2033 (USD Million)
Table 94 Sweden Liquid Biopsy Market, By Clinical Application, 2021 - 2033 (USD Million)
Table 95 Sweden Liquid Biopsy Market, By Product, 2021 - 2033 (USD Million)
Table 96 Norway Liquid Biopsy Market, By Sample Type, 2021 - 2033 (USD Million)
Table 97 Norway Liquid Biopsy Market, By Biomarker, 2021 - 2033 (USD Million)
Table 98 Norway Liquid Biopsy Market, By Technology, 2021 - 2033 (USD Million)
Table 99 Norway Liquid Biopsy Market, By Application, 2021 - 2033 (USD Million)
Table 100 Norway Liquid Biopsy Market, By End Use, 2021 - 2033 (USD Million)
Table 101 Norway Liquid Biopsy Market, By Clinical Application, 2021 - 2033 (USD Million)
Table 102 Norway Liquid Biopsy Market, By Product, 2021 - 2033 (USD Million)
Table 103 Asia Pacific Liquid Biopsy Market, By Country, 2021 - 2033 (USD Million)
Table 104 Asia Pacific Liquid Biopsy Market, By Sample Type, 2021 - 2033 (USD Million)
Table 105 Asia Pacific Liquid Biopsy Market, By Biomarker, 2021 - 2033 (USD Million)
Table 106 Asia Pacific Liquid Biopsy Market, By Technology, 2021 - 2033 (USD Million)
Table 107 Asia Pacific Liquid Biopsy Market, By Application, 2021 - 2033 (USD Million)
Table 108 Asia Pacific Liquid Biopsy Market, By End Use, 2021 - 2033 (USD Million)
Table 109 Asia Pacific Liquid Biopsy Market, By Clinical Application, 2021 - 2033 (USD Million)
Table 110 Asia Pacific Liquid Biopsy Market, By Product, 2021 - 2033 (USD Million)
Table 111 Japan Liquid Biopsy Market, By Sample Type, 2021 - 2033 (USD Million)
Table 112 Japan Liquid Biopsy Market, By Biomarker, 2021 - 2033 (USD Million)
Table 113 Japan Liquid Biopsy Market, By Technology, 2021 - 2033 (USD Million)
Table 114 Japan Liquid Biopsy Market, By Application, 2021 - 2033 (USD Million)
Table 115 Japan Liquid Biopsy Market, By End Use, 2021 - 2033 (USD Million)
Table 116 Japan Liquid Biopsy Market, By Clinical Application, 2021 - 2033 (USD Million)
Table 117 Japan Liquid Biopsy Market, By Product, 2021 - 2033 (USD Million)
Table 118 China Liquid Biopsy Market, By Sample Type, 2021 - 2033 (USD Million)
Table 119 China Liquid Biopsy Market, By Biomarker, 2021 - 2033 (USD Million)
Table 120 China Liquid Biopsy Market, By Technology, 2021 - 2033 (USD Million)
Table 121 China Liquid Biopsy Market, By Application, 2021 - 2033 (USD Million)
Table 122 China Liquid Biopsy Market, By End Use, 2021 - 2033 (USD Million)
Table 123 China Liquid Biopsy Market, By Clinical Application, 2021 - 2033 (USD Million)
Table 124 China Liquid Biopsy Market, By Product, 2021 - 2033 (USD Million)
Table 125 India Liquid Biopsy Market, By Sample Type, 2021 - 2033 (USD Million)
Table 126 India Liquid Biopsy Market, By Biomarker, 2021 - 2033 (USD Million)
Table 127 India Liquid Biopsy Market, By Technology, 2021 - 2033 (USD Million)
Table 128 India Liquid Biopsy Market, By Application, 2021 - 2033 (USD Million)
Table 129 India Liquid Biopsy Market, By End Use, 2021 - 2033 (USD Million)
Table 130 India Liquid Biopsy Market, By Clinical Application, 2021 - 2033 (USD Million)
Table 131 India Liquid Biopsy Market, By Product, 2021 - 2033 (USD Million)
Table 132 Australia Liquid Biopsy Market, By Sample Type, 2021 - 2033 (USD Million)
Table 133 Australia Liquid Biopsy Market, By Biomarker, 2021 - 2033 (USD Million)
Table 134 Australia Liquid Biopsy Market, By Technology, 2021 - 2033 (USD Million)
Table 135 Australia Liquid Biopsy Market, By Application, 2021 - 2033 (USD Million)
Table 136 Australia Liquid Biopsy Market, By End Use, 2021 - 2033 (USD Million)
Table 137 Australia Liquid Biopsy Market, By Clinical Application, 2021 - 2033 (USD Million)
Table 138 Australia Liquid Biopsy Market, By Product, 2021 - 2033 (USD Million)
Table 139 South Korea Liquid Biopsy Market, By Sample Type, 2021 - 2033 (USD Million)
Table 140 South Korea Liquid Biopsy Market, By Biomarker, 2021 - 2033 (USD Million)
Table 141 South Korea Liquid Biopsy Market, By Technology, 2021 - 2033 (USD Million)
Table 142 South Korea Liquid Biopsy Market, By Application, 2021 - 2033 (USD Million)
Table 143 South Korea Liquid Biopsy Market, By End Use, 2021 - 2033 (USD Million)
Table 144 South Korea Liquid Biopsy Market, By Clinical Application, 2021 - 2033 (USD Million)
Table 145 South Korea Liquid Biopsy Market, By Product, 2021 - 2033 (USD Million)
Table 146 Thailand Liquid Biopsy Market, By Sample Type, 2021 - 2033 (USD Million)
Table 147 Thailand Liquid Biopsy Market, By Biomarker, 2021 - 2033 (USD Million)
Table 148 Thailand Liquid Biopsy Market, By Technology, 2021 - 2033 (USD Million)
Table 149 Thailand Liquid Biopsy Market, By Application, 2021 - 2033 (USD Million)
Table 150 Thailand Liquid Biopsy Market, By End Use, 2021 - 2033 (USD Million)
Table 151 Thailand Liquid Biopsy Market, By Clinical Application, 2021 - 2033 (USD Million)
Table 152 Thailand Liquid Biopsy Market, By Product, 2021 - 2033 (USD Million)
Table 153 Latin America Liquid Biopsy Market, By Country, 2021 - 2033 (USD Million)
Table 154 Latin America Liquid Biopsy Market, By Sample Type, 2021 - 2033 (USD Million)
Table 155 Latin America Liquid Biopsy Market, By Biomarker, 2021 - 2033 (USD Million)
Table 156 Latin America Liquid Biopsy Market, By Technology, 2021 - 2033 (USD Million)
Table 157 Latin America Liquid Biopsy Market, By Application, 2021 - 2033 (USD Million)
Table 158 Latin America Liquid Biopsy Market, By End Use, 2021 - 2033 (USD Million)
Table 159 Latin America Liquid Biopsy Market, By Clinical Application, 2021 - 2033 (USD Million)
Table 160 Latin America Liquid Biopsy Market, By Product, 2021 - 2033 (USD Million)
Table 161 Brazil Liquid Biopsy Market, By Sample Type, 2021 - 2033 (USD Million)
Table 162 Brazil Liquid Biopsy Market, By Biomarker, 2021 - 2033 (USD Million)
Table 163 Brazil Liquid Biopsy Market, By Technology, 2021 - 2033 (USD Million)
Table 164 Brazil Liquid Biopsy Market, By Application, 2021 - 2033 (USD Million)
Table 165 Brazil Liquid Biopsy Market, By End Use, 2021 - 2033 (USD Million)
Table 166 Brazil Liquid Biopsy Market, By Clinical Application, 2021 - 2033 (USD Million)
Table 167 Brazil Liquid Biopsy Market, By Product, 2021 - 2033 (USD Million)
Table 168 Argentina Liquid Biopsy Market, By Sample Type, 2021 - 2033 (USD Million)
Table 169 Argentina Liquid Biopsy Market, By Biomarker, 2021 - 2033 (USD Million)
Table 170 Argentina Liquid Biopsy Market, By Technology, 2021 - 2033 (USD Million)
Table 171 Argentina Liquid Biopsy Market, By Application, 2021 - 2033 (USD Million)
Table 172 Argentina Liquid Biopsy Market, By End Use, 2021 - 2033 (USD Million)
Table 173 Argentina Liquid Biopsy Market, By Clinical Application, 2021 - 2033 (USD Million)
Table 174 Argentina Liquid Biopsy Market, By Product, 2021 - 2033 (USD Million)
Table 175 Middle East & Africa Liquid Biopsy Market, By Country, 2021 - 2033 (USD Million)
Table 176 Middle East & Africa Liquid Biopsy Market, By Sample Type, 2021 - 2033 (USD Million)
Table 177 Middle East & Africa Liquid Biopsy Market, By Biomarker, 2021 - 2033 (USD Million)
Table 178 Middle East & Africa Liquid Biopsy Market, By Technology, 2021 - 2033 (USD Million)
Table 179 Middle East & Africa Liquid Biopsy Market, By Application, 2021 - 2033 (USD Million)
Table 180 Middle East & Africa Liquid Biopsy Market, By End Use, 2021 - 2033 (USD Million)
Table 181 Middle East & Africa Liquid Biopsy Market, By Clinical Application, 2021 - 2033 (USD Million)
Table 182 Middle East & Africa Liquid Biopsy Market, By Product, 2021 - 2033 (USD Million)
Table 183 South Africa Liquid Biopsy Market, By Sample Type, 2021 - 2033 (USD Million)
Table 184 South Africa Liquid Biopsy Market, By Biomarker, 2021 - 2033 (USD Million)
Table 185 South Africa Liquid Biopsy Market, By Technology, 2021 - 2033 (USD Million)
Table 186 South Africa Liquid Biopsy Market, By Application, 2021 - 2033 (USD Million)
Table 187 South Africa Liquid Biopsy Market, By End Use, 2021 - 2033 (USD Million)
Table 188 South Africa Liquid Biopsy Market, By Clinical Application, 2021 - 2033 (USD Million)
Table 189 South Africa Liquid Biopsy Market, By Product, 2021 - 2033 (USD Million)
Table 190 Saudi Arabia Liquid Biopsy Market, By Sample Type, 2021 - 2033 (USD Million)
Table 191 Saudi Arabia Liquid Biopsy Market, By Biomarker, 2021 - 2033 (USD Million)
Table 192 Saudi Arabia Liquid Biopsy Market, By Technology, 2021 - 2033 (USD Million)
Table 193 Saudi Arabia Liquid Biopsy Market, By Application, 2021 - 2033 (USD Million)
Table 194 Saudi Arabia Liquid Biopsy Market, By End Use, 2021 - 2033 (USD Million)
Table 195 Saudi Arabia Liquid Biopsy Market, By Clinical Application, 2021 - 2033 (USD Million)
Table 196 Saudi Arabia Liquid Biopsy Market, By Product, 2021 - 2033 (USD Million)
Table 197 UAE Liquid Biopsy Market, By Sample Type, 2021 - 2033 (USD Million)
Table 198 UAE Liquid Biopsy Market, By Biomarker, 2021 - 2033 (USD Million)
Table 199 UAE Liquid Biopsy Market, By Technology, 2021 - 2033 (USD Million)
Table 200 UAE Liquid Biopsy Market, By Application, 2021 - 2033 (USD Million)
Table 201 UAE Liquid Biopsy Market, By End Use, 2021 - 2033 (USD Million)
Table 202 UAE Liquid Biopsy Market, By Clinical Application, 2021 - 2033 (USD Million)
Table 203 UAE Liquid Biopsy Market, By Product, 2021 - 2033 (USD Million)
Table 204 Kuwait Liquid Biopsy Market, By Sample Type, 2021 - 2033 (USD Million)
Table 205 Kuwait Liquid Biopsy Market, By Biomarker, 2021 - 2033 (USD Million)
Table 206 Kuwait Liquid Biopsy Market, By Technology, 2021 - 2033 (USD Million)
Table 207 Kuwait Liquid Biopsy Market, By Application, 2021 - 2033 (USD Million)
Table 208 Kuwait Liquid Biopsy Market, By End Use, 2021 - 2033 (USD Million)
Table 209 Kuwait Liquid Biopsy Market, By Clinical Application, 2021 - 2033 (USD Million)
Table 210 Kuwait Liquid Biopsy Market, By Product, 2021 - 2033 (USD Million)

List of Figures

Fig. 1 Market research process
Fig. 2 Information procurement
Fig. 3 Primary research pattern
Fig. 4 Market research approaches
Fig. 5 Value chain-based sizing & forecasting
Fig. 6 Market formulation & validation
Fig. 7 Liquid biopsy market segmentation
Fig. 8 Market driver relevance analysis (Current & future impact)
Fig. 9 Market restraint relevance analysis (Current & future impact)
Fig. 10 Market challenge relevance analysis (Current & future impact)
Fig. 11 Penetration & growth prospect mapping
Fig. 12 SWOT analysis, by factor (political & legal, economic and technological)
Fig. 13 Porter’s five forces analysis
Fig. 14 Market penetration vs growth prospect mapping
Fig. 15 Liquid biopsy market: Sample Type movement analysis
Fig. 16 Blood sample liquid biopsy market, 2021 - 2033 (USD Million)
Fig. 17 Others liquid biopsy market, 2021 - 2033 (USD Million)
Fig. 18 Liquid biopsy market: Biomarker movement analysis
Fig. 19 Circulating Tumor Cells (CTCs) liquid biopsy market, 2021 - 2033 (USD Million)
Fig. 20 Circulating Nucleic Acids liquid biopsy market, 2021 - 2033 (USD Million)
Fig. 21 Exosomes/Microvesicles liquid biopsy market, 2021 - 2033 (USD Million)
Fig. 22 Others liquid biopsy market, 2021 - 2033 (USD Million)
Fig. 23 Liquid biopsy market: Technology movement analysis
Fig. 24 Multi-gene-parallel analysis (NGS) liquid biopsy market, 2021 - 2033 (USD Million)
Fig. 25 Single gene analysis (PCR Microarrays) liquid biopsy market, 2021 - 2033 (USD Million)
Fig. 26 Liquid biopsy market: Application movement analysis
Fig. 27 Cancer liquid biopsy market, 2021 - 2033 (USD Million)
Fig. 28 Lung cancer liquid biopsy market, 2021 - 2033 (USD Million)
Fig. 29 Prostate cancer liquid biopsy market, 2021 - 2033 (USD Million)
Fig. 30 Breast cancer liquid biopsy market, 2021 - 2033 (USD Million)
Fig. 31 Colorectal cancer liquid biopsy market, 2021 - 2033 (USD Million)
Fig. 32 Leukemia liquid biopsy market, 2021 - 2033 (USD Million)
Fig. 33 Gastrointestinal cancer liquid biopsy market, 2021 - 2033 (USD Million)
Fig. 34 Others liquid biopsy market, 2021 - 2033 (USD Million)
Fig. 35 Reproductive Health liquid biopsy market, 2021 - 2033 (USD Million)
Fig. 36 Others liquid biopsy market, 2021 - 2033 (USD Million)
Fig. 37 Liquid biopsy market: End Use movement analysis
Fig. 38 Hospitals and Laboratories liquid biopsy market, 2021 - 2033 (USD Million)
Fig. 39 Specialty clinics liquid biopsy market, 2021 - 2033 (USD Million)
Fig. 40 Academic and research centers liquid biopsy market, 2021 - 2033 (USD Million)
Fig. 41 Others liquid biopsy market, 2021 - 2033 (USD Million)
Fig. 42 Liquid biopsy market: Clinical application movement analysis
Fig. 43 Therapy selection liquid biopsy market, 2021 - 2033 (USD Million)
Fig. 44 Treatment monitoring liquid biopsy market, 2021 - 2033 (USD Million)
Fig. 45 Early cancer screening liquid biopsy market, 2021 - 2033 (USD Million)
Fig. 46 Recurrence monitoring liquid biopsy market, 2021 - 2033 (USD Million)
Fig. 47 Others liquid biopsy market, 2021 - 2033 (USD Million)
Fig. 48 Liquid biopsy market: Product movement analysis
Fig. 49 Instruments liquid biopsy market, 2021 - 2033 (USD Million)
Fig. 50 Consumables kits and reagents liquid biopsy market, 2021 - 2033 (USD Million)
Fig. 51 Software and Services liquid biopsy market, 2021 - 2033 (USD Million)
Fig. 52 Regional marketplace: Key takeaways
Fig. 53 Regional outlook, 2021 & 2033
Fig. 54 North America liquid biopsy market, 2021 - 2033 (USD Million)
Fig. 55 U.S. liquid biopsy market, 2021 - 2033 (USD Million)
Fig. 56 Canada liquid biopsy market, 2021 - 2033 (USD Million)
Fig. 57 Mexico liquid biopsy market, 2021 - 2033 (USD Million)
Fig. 58 Europe liquid biopsy market, 2021 - 2033 (USD Million)
Fig. 59 UK liquid biopsy market, 2021 - 2033 (USD Million)
Fig. 60 Germany liquid biopsy market, 2021 - 2033 (USD Million)
Fig. 61 Italy liquid biopsy market, 2021 - 2033 (USD Million)
Fig. 62 Spain liquid biopsy market, 2021 - 2033 (USD Million)
Fig. 63 France liquid biopsy market, 2021 - 2033 (USD Million)
Fig. 64 Denmark liquid biopsy market, 2021 - 2033 (USD Million)
Fig. 65 Sweden liquid biopsy market, 2021 - 2033 (USD Million)
Fig. 66 Norway liquid biopsy market, 2021 - 2033 (USD Million)
Fig. 67 Asia Pacific liquid biopsy market, 2021 - 2033 (USD Million)
Fig. 68 Japan liquid biopsy market, 2021 - 2033 (USD Million)
Fig. 69 China liquid biopsy market, 2021 - 2033 (USD Million)
Fig. 70 India liquid biopsy market, 2021 - 2033 (USD Million)
Fig. 71 Australia liquid biopsy market, 2021 - 2033 (USD Million)
Fig. 72 South Korea liquid biopsy market, 2021 - 2033 (USD Million)
Fig. 73 Thailand liquid biopsy market, 2021 - 2033 (USD Million)
Fig. 74 Latin America liquid biopsy market, 2021 - 2033 (USD Million)
Fig. 75 Brazil liquid biopsy market, 2021 - 2033 (USD Million)
Fig. 76 Argentina liquid biopsy market, 2021 - 2033 (USD Million)
Fig. 77 Middle East and Africa liquid biopsy market, 2021 - 2033 (USD Million)
Fig. 78 South Africa liquid biopsy market, 2021 - 2033 (USD Million)
Fig. 79 Saudi Arabia liquid biopsy market, 2021 - 2033 (USD Million)
Fig. 80 UAE liquid biopsy market, 2021 - 2033 (USD Million)
Fig. 81 Kuwait liquid biopsy market, 2021 - 2033 (USD Million)